US Stock MarketDetailed Quotes

ASRT Assertio

Watchlist
  • 0.842
  • -0.013-1.57%
Close Feb 14 16:00 ET
  • 0.841
  • -0.001-0.06%
Post 20:01 ET
80.35MMarket Cap-1.91P/E (TTM)

About Assertio Company

Assertio Holdings, Inc. is a commercial pharmaceutical company, which engages in acquisitions, licensing, and mergers. The firm focuses on portfolio of neurology, inflammation, and pain medications. Its products include INDOCIN, Sympazan, Otrexup, SPRIX, CAMBIA, and Zipsor. The company was founded on August 7, 1995 and is headquartered in Lake Forest, IL.

Company Profile

SymbolASRT
Company NameAssertio
Listing DateDec 2, 1997
Founded1995
CEOMs. Heather L. Mason
MarketNASDAQ
Employees53
Fiscal Year Ends12-31
Address100 South Saunders Road,Suite 300
CityLake Forest
ProvinceIllinois
CountryUnited States of America
Zip Code60045
Phone1-224-419-7106
Websitehttp://www.assertiotx.com

Company Executives

  • Name
  • Position
  • Salary
  • Brendan P. O’Grady
  • Co-Chief Executive Officer
  • --
  • Ajay Patel
  • Senior Vice President, Chief Financial Officer and Chief Accounting Officer
  • 1.06M
  • Paul Schwichtenberg
  • Chief Transformation Officer
  • 1.09M
  • Mary Pietryga
  • Chief Commercial Officer
  • --
  • Sam Schlessinger
  • Senior Vice President and General Counsel
  • --
  • Heather L. Mason
  • Chairman of the Board
  • 353.02K
  • Mark Reisenauer
  • Director
  • --
  • James L. Tyree
  • Independent Director
  • 346.89K
  • David Matthew Stark
  • Independent Director
  • --
  • William T. Mckee
  • Independent Director
  • 356.52K
  • Sravan K. Emany
  • Independent Director
  • 223.80K
  • Sigurd C. Kirk
  • Independent Director
  • --

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
PILOT
831175
+30.00%
XINGANJIANG
873167
+29.99%
Beijing Highlander Digital Technology
300065
+20.05%
4
Hangzhou Gaoxin Materials Technology
300478
+20.02%
5
Shijihengtong Technology
301428
+20.01%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Earnings Season Underway
Earnings season is here. What to know?
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More
TSLA earnings preview: Grab rewards by guessing the opening price!